74 related articles for article (PubMed ID: 15878437)
1. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli.
Lionakis MS; Lewis RE; Torres HA; Albert ND; Raad II; Kontoyiannis DP
Diagn Microbiol Infect Dis; 2005 May; 52(1):15-20. PubMed ID: 15878437
[TBL] [Abstract][Full Text] [Related]
2. In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole.
Sutton DA; Sanche SE; Revankar SG; Fothergill AW; Rinaldi MG
J Clin Microbiol; 1999 Jul; 37(7):2343-5. PubMed ID: 10364610
[TBL] [Abstract][Full Text] [Related]
3. Challenging fungal infections in cystic fibrosis: a case of mixed Aspergillus species infection and antifungal combination testing.
Pontes L; Reichert-Lima F; Perini Leme Giordano AL; Moretti ML; Zaninelli Schreiber A
Access Microbiol; 2024; 6(4):. PubMed ID: 38737802
[No Abstract] [Full Text] [Related]
4. Investigation of antifungal susceptibility of Aspergillus species isolated from systemic clinical specimens by different methods.
Korkmaz E; Ergon MC
Indian J Med Microbiol; 2024 Jun; 50():100642. PubMed ID: 38830536
[TBL] [Abstract][Full Text] [Related]
5. Effect of reduced oxygen on the antifungal susceptibility of clinically relevant aspergilli.
Binder U; Maurer E; Lackner M; Lass-Flörl C
Antimicrob Agents Chemother; 2015 Mar; 59(3):1806-10. PubMed ID: 25547350
[TBL] [Abstract][Full Text] [Related]
6. Genetic Analyses of Amphotericin B Susceptibility in
Fan Y; Korfanty GA; Xu J
J Fungi (Basel); 2021 Oct; 7(10):. PubMed ID: 34682281
[No Abstract] [Full Text] [Related]
7. Catching some air: a method to spatially quantify aerial triazole resistance in
Kortenbosch HH; van Leuven F; van den Heuvel C; Schoustra SE; Zwaan BJ; Snelders E
Appl Environ Microbiol; 2024 Jun; ():e0027124. PubMed ID: 38842339
[TBL] [Abstract][Full Text] [Related]
8. Mycetoma due to
Kamali Sarvestani H; Ahmadi B; Gerami Shoar M; Getso M; Rafat Z; Mahmoudi S; Khansari M; Salahshour F; Fatahi L; Salehi M; Ansari S
IDCases; 2022; 29():e01585. PubMed ID: 35928000
[TBL] [Abstract][Full Text] [Related]
9. Recent Trends in the Epidemiology of Fungal Infections.
Seagle EE; Williams SL; Chiller TM
Infect Dis Clin North Am; 2021 Jun; 35(2):237-260. PubMed ID: 34016277
[TBL] [Abstract][Full Text] [Related]
10. Central Nervous System Infections Due to Aspergillus and Other Hyaline Molds.
Miceli MH
J Fungi (Basel); 2019 Aug; 5(3):. PubMed ID: 31480311
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of culture-positive invasive pulmonary aspergillosis in patients with hematologic diseases: Comparison between Aspergillus fumigatus and non-fumigatus Aspergillus species.
Cho SY; Lee DG; Choi JK; Lee HJ; Kim SH; Park SH; Choi SM; Choi JH; Yoo JH; Park YJ; Lee JW
Medicine (Baltimore); 2017 Dec; 96(49):e8841. PubMed ID: 29245249
[TBL] [Abstract][Full Text] [Related]
12. Circulating
Alanio A; Menotti J; Gits-Muselli M; Hamane S; Denis B; Rafoux E; Peffault de la Tour R; Touratier S; Bergeron A; Guigue N; Bretagne S
Front Microbiol; 2017; 8():2040. PubMed ID: 29163378
[TBL] [Abstract][Full Text] [Related]
13. Caspofungin Treatment of Aspergillus fumigatus Results in ChsG-Dependent Upregulation of Chitin Synthesis and the Formation of Chitin-Rich Microcolonies.
Walker LA; Lee KK; Munro CA; Gow NA
Antimicrob Agents Chemother; 2015 Oct; 59(10):5932-41. PubMed ID: 26169407
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic methods for invasive fungal diseases in patients with hematologic malignancies.
Riwes MM; Wingard JR
Expert Rev Hematol; 2012 Dec; 5(6):661-9. PubMed ID: 23216596
[TBL] [Abstract][Full Text] [Related]
15. Analysis of promoter function in Aspergillus fumigatus.
Paul S; Klutts JS; Moye-Rowley WS
Eukaryot Cell; 2012 Sep; 11(9):1167-77. PubMed ID: 22843562
[TBL] [Abstract][Full Text] [Related]
16. Resistance to voriconazole due to a G448S substitution in Aspergillus fumigatus in a patient with cerebral aspergillosis.
Pelaez T; Gijón P; Bunsow E; Bouza E; Sánchez-Yebra W; Valerio M; Gama B; Cuenca-Estrella M; Mellado E
J Clin Microbiol; 2012 Jul; 50(7):2531-4. PubMed ID: 22573589
[TBL] [Abstract][Full Text] [Related]
17. Invasive aspergillosis: resistance to antifungal drugs.
Hadrich I; Makni F; Neji S; Abbes S; Cheikhrouhou F; Trabelsi H; Sellami H; Ayadi A
Mycopathologia; 2012 Aug; 174(2):131-41. PubMed ID: 22327841
[TBL] [Abstract][Full Text] [Related]
18. Role of Aspergillus lentulus 14-α sterol demethylase (Cyp51A) in azole drug susceptibility.
Mellado E; Alcazar-Fuoli L; Cuenca-Estrella M; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2011 Dec; 55(12):5459-68. PubMed ID: 21947395
[TBL] [Abstract][Full Text] [Related]
19. Current approaches in antifungal prophylaxis in high risk hematologic malignancy and hematopoietic stem cell transplant patients.
Wirk B; Wingard JR
Mycopathologia; 2009 Dec; 168(6):299-311. PubMed ID: 19247798
[TBL] [Abstract][Full Text] [Related]
20. Molecular typing of Aspergillus terreus isolates collected in Houston, Texas, and Innsbruck, Austria: evidence of great genetic diversity.
Lass-Flörl C; Grif K; Kontoyiannis DP
J Clin Microbiol; 2007 Aug; 45(8):2686-90. PubMed ID: 17581930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
